SEPTEMBER 5, 2025, NEW YORK – The most common and aggressive type of adult brain cancer, glioblastoma multiforme (GBM) is notoriously resistant to treatment, with a median survival of just 14 months ...
An international team of scientists has revealed how rogue rings of DNA that float outside of our chromosomes—known as extrachromosomal DNA, or ecDNA—can drive the growth of a large proportion of ...
Scientists in South Korea have discovered that one of the most common malignant brain tumors in young adults may begin years before a tumor can be seen. IDH-mutant glioma, long treated by removing ...
The most common and aggressive type of adult brain cancer, glioblastoma multiforme (GBM) is notoriously resistant to treatment, with a median survival of just 14 months following diagnosis. Its ...
A groundbreaking study from Brown University Health researchers has identified a crucial factor that may help improve treatment for glioblastoma, one of the most aggressive and common forms of adult ...
Vietnam Investment Review on MSN
Telix resubmits brain cancer imaging drug application to FDA
MELBOURNE, Australia and INDIANAPOLIS, March 16, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces the resubmission of a New Drug Application (NDA) to ...
Add Yahoo as a preferred source to see more of our stories on Google. BrainIAC, a new AI model, analyzes brain MRIs to predict dementia risk, tumor mutations, and brain cancer survival. (CREDIT: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results